Entity
  • Skyepharma

    Created in 1993


  • Up & running (A)
    Existing signals show a regular activity
  • Social networks

    10,571
  • Activities

  • Technologies

  • Entity types

  • Location

    55 Rue du Montmurier, 38070 Saint-Quentin-Fallavier, France

    Saint-Quentin-Fallavier

    France

  • Employees

    Scale: 201-500

    Estimated: 226

  • SIREN

    409600616
  • Engaged catalyst

    14
    0 0
  • Added in Motherbase

    4 years, 2 months ago
Description
  • Value proposition

    Expert and agile fully integrated CDMO - specializing in classic and complex oral solid forms.


    Through many years of involvement and achievements in the pharmaceutical industry, Skyepharma’s development and manufacturing facility is eminently specialized in Complex Oral Solid Dosage Forms.

    We have the ability to provide customized solutions to our customers by positioning ourselves as a One-Stop-Shop player and a privileged partner offering a wide range of premium services.

    Our State-of-the Art CDMO facility close to Lyon (France) provides solutions bringing value to our clients at any stage of a product development lifecycle, from small scale programs up to commercial manufacturing and packaging activities.

    Our value proposal includes tailored services to clients’ requirements supporting them up to market introduction.

    For more information on Skyepharma, please visit www.skyepharma.com

    Scale Up, Manufacturing of clinical trial materials, Technology Transfer, Bulk Manufacturing, Analytical Development, Packaging, formulation and process development, Quality, Serialization, CDMO, CMO, multi-layer tablet, tab in tab, Oral solid dosage form, quality by design, Regulatory, Controlled release, Aggregation, FDA Approved, life cycle management, external manufacturing, one stop shop, and CRO

  • Original language

    Expert and agile fully integrated CDMO - specializing in classic and complex oral solid forms.


    Through many years of involvement and achievements in the pharmaceutical industry, Skyepharma’s development and manufacturing facility is eminently specialized in Complex Oral Solid Dosage Forms.

    We have the ability to provide customized solutions to our customers by positioning ourselves as a One-Stop-Shop player and a privileged partner offering a wide range of premium services.

    Our State-of-the Art CDMO facility close to Lyon (France) provides solutions bringing value to our clients at any stage of a product development lifecycle, from small scale programs up to commercial manufacturing and packaging activities.

    Our value proposal includes tailored services to clients’ requirements supporting them up to market introduction.

    For more information on Skyepharma, please visit www.skyepharma.com

  • Skyepharma fully integrated CDMO for complex oral solid forms

    Skyepharma is an agile CDMO with expertise in classic and complex oral solid dosage forms. We provide tailor-made solutions to our customers.

  • https://www.skyepharma.com/
Catalyst interactions
Catalyst TypeTweets Articles
Le Figaro
Le Figaro
Media, Newspaper Publishing
Le Figaro
Media, Newspaper Publishing
Other

15 Feb 2023


ONLYLYON
ONLYLYON
National and local authorities, Non-profit Organizations
ONLYLYON
National and local authorities, Non-profit Organizations
Other

28 Sep 2024


Lyonbiopôle Auvergne-Rhône-Alpes
Lyonbiopôle Auvergne-Rhône-Alpes
Public business cluster, Biotechnology, French Cluster, Biotechnology Research
Lyonbiopôle Auvergne-Rhône-Alpes
Public business cluster, Biotechnology, French Cluster, Biotechnology Research
Other

29 Jul 2024


Bpifrance
Bpifrance
Bank, Banking
Bpifrance
Bank, Banking
Other

25 Oct 2023


Social network dynamics
Loading...